Method development and validation of montelukast in human plasma by HPLC coupled with ESI-MS/MS: Application to a bioequivalence study

Scientia Pharmaceutica

Volumn 78, Issue 3, 2010, Pages 411-422

  Challa, Balasekhara Reddy ^a,b   Awen, Bahlul Z ^c   Chandu, Babu Rao ^c   Khagga, Mukkanti ^d   Kotthapalli, Chandrasekhar Bannoth ^a  

^a JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^b Nalanda Educational Society   (India)

^c Aljabal Algharbi University   (Libyan Arab Jamahiriya)

^d JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Bioequivalence study; LC ESI MS MS; Montelukast

Indexed keywords

ACETONITRILE; AMMONIUM FORMATE; MONTELUKAST; PROTON;

ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CHROMATOGRAPHY; DIET RESTRICTION; DRUG ISOLATION; ELECTROSPRAY MASS SPECTROMETRY; FREEZE THAWING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MONITORING; NORMAL HUMAN; TANDEM MASS SPECTROMETRY;

EID: 77957347788     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1002-07     Document Type: Article

References (20)

1. http://en.wikipedia.org/wiki/Montelukast
2. Bharathi DV, Hotha KK, Jagadeesh B, Mullangi R, Naidu A. Quantification of montelukast, selective cysteinyl leukotriene receptor (CysLT1) antagonist In human plasma by liquid chromatography-mass spectrometry- validation and its application to a human pharmacokinetic study. Biomed Chromatogr. 2009; 23: 804-810. doi:10.1002/bmc.1189
3. Sripalakit P, Kongthong B, Saraphanchotiwitthaya A. A simple bioanalytical assay for determination of montelukast in human plasma- application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 869: 38-44. doi:10.1016/j.jchromb.2008.05.017
4. Liu L, Cheng H, Zhao JJ,Rogers JD. Determination of montelukast (MK-0476) and its S- enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J Pharm Biomed Anal. 1997; 15: 631-638. doi:10.1016/S0731-7085(96)01894-8
5. Ochiai H, Uchiyama N, Takano T, Hara K, Amei T. Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection. J Chromatogr B Biomed Sci Appl. 1998; 713: 409-414. doi:10.1016/S0378-4347(98)00179-0
6. Smith GA, Rawls CM, Kunka RL. An automated method for the determination of montelukast in human plasma using dual-column HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm Res. 2004; 21: 1539-1544. doi:10.1023/B:PHAM.0000041445.76931.27
7. Kitchen CJ, Wang AQ, Musson DG, Yang AY, Fisher AL. Semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J Pharm Biomed Anal.2003; 31: 647-654. doi:10.1016/S0731-7085(02)00723-9
8. Al-Rawithi S, Al-Gazlan S, Al-Ahmadi W, Alshowaier IA, Yusuf A, Raines DA. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. J Chromatogr B Biomed Sci Appl. 2001; 754: 527-531. doi:10.1016/S0378-4347(01)00025-1
9. Papp R, Luk P, Mullett WM, Kwong E. A rapid and sensitive method for the quantitation of montelukast in sheep plasma using liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 858: 282-286. doi:10.1016/j.jchromb.2007.08.003
10. Alsarra I, Al-Omar M, Gadkariem EA, Belal F. Voltammetric determination of montelukast sodium in dosage forms and human plasma. Farmaco. 2005; 60: 563-567. doi:10.1016/j.farmac.2005.04.004
11. Saravanan M, Siva Kumari K, Pratap Reddy P, Naidu MN, Moses Babu J, Srivastava AK, Lakshmi Kumar T, Chandra Sekhar BV, Satyanarayana B. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium. J Pharm Biomed Anal. 2008; 48: 708-715. doi:10.1016/j.jpba.2008.07.007
12. Shakalisava Y, Regan F. Determination of montelukast sodium by capillary electrophoresis. J Sep Sci. 2008; 31: 1137-1143. doi:10.1002/jssc.200700591
13. Al Omari MM, Zoubi RM, Hasan EI, Khader TZ, Badwan AA. Effect of light and heat on the stability of montelukast in solution and in its solid state. J Pharm Biomed Anal. 2007; 45: 465-471. doi:10.1016/j.jpba.2007.07.014
14. Hoang TH, Sharma R, Susanto D, Di Maso M, Kwong E. Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms. J Chromatogr A. 2007; 1156: 149-153. doi:10.1016/j.chroma.2007.02.060
15. Alsarra I, Khalil NY, Sultan M, Al-Ashban R, Belal F. Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma. Pharmazie. 2005; 60: 823-826. PMid:16320943
16. Radhakrishna T, Narasaraju A, Ramakrishna M, Satyanarayana A. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J Pharm Biomed Anal. 2003; 31: 359-368. doi:10.1016/S0731-7085(02)00650-7
17. Saeed Arayne M, Sultana N, Hussain F. Spectrophotometric method for quantitative determination of montelukast in bulk, pharmaceutical formulations and human serum. J Anal Chem. 2009; 64: 690-695. doi:10.1134/S1061934809070065
18. Guidance for industry: bioanalytical method validation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 2001.
19. Guidance for industry Food- effect bio availability and Fed Bio equivalence studies. U.S. Department of Health and Human services Food and Drug Administration Centre for Drug Evaluation and research (CDER) December 2002.
20. Guidance for industry Bio availability and Fed Bio equivalence Studies for Orally Administered Drug Products-General considerations U.S. Department of Health and Human services Food and Drug Administration Centre for Drug Evaluation and research (CDER) March 2003.